← FDA DRUG APPROVALS

FDA ANDA · ANDA083724

ISOPROTERENOL HYDROCHLORIDE

Sponsor: INTL MEDICATION

APPLICATION
ANDA083724
TYPE
ANDA
ORIGINAL APPROVAL
1976-01-06
LATEST ACTION
1998-07-16
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ISOPROTERENOL HYDROCHLORIDEDiscontinued
ISOPROTERENOL HYDROCHLORIDE 0.2MG/ML · INJECTABLE · INJECTION

Approval history

1998-07-16Labeling · Supplement 15AP
1996-09-27Labeling · Supplement 14AP
1995-09-19Manufacturing (CMC) · Supplement 13AP
1994-06-17Manufacturing (CMC) · Supplement 12AP
1993-10-29Manufacturing (CMC) · Supplement 11AP
1991-12-27Labeling · Supplement 10AP
1987-04-23Manufacturing (CMC) · Supplement 3AP
1976-01-06OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →